Paul Rothman - Jun 6, 2024 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Paul Rothman
Stock symbol
LH
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/10/2024, 08:52 AM
Previous filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +717 717 Jun 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -717 -43.17% $0.00 944 Jun 6, 2024 Common Stock 717 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2 The Restricted Stock Units vested fully on June 6, 2024.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Remarks:

On May 17, 2024, Labcorp Holdings Inc. ("LHI") became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.